Should diversity be mandatory in U.K Clinical Trials?
The clinical trial industry has always struggled with diverse recruitment within their trials. One study by A. Stuart and E. Harrison found that only 5% of respondents from ethnic minority groups in the UK had ever participated in a Clinical Trial. In October 2020, of the 270,000 individuals recruited for the Covid-19 vaccine trials, only 7% were […]
Digital Transformation in the Life Science Industry
Digital Transformation is developing new high tech ways or modifying existing systems to help a company progress, it can help with the ever changing Life Science industry and market requirements. For a company to grow and succeed, digital transformation is now a strategic imperative. The Life Science industry has been impacted already by different events […]
Mantell Associates Network: Q&A with Kåre Engkilde
As part of the Mantell Associates Network podcast earlier last year, CEO Alessandro Mantell welcomed Kåre Engkilde. On Episode 17 of the Mantell Associates Network Podcast we welcomed Kåre Engkilde, CEO at Amniotics, a biopharmaceutical company based in Sweden dedicated to providing unique stem cell therapeutics to patients in need. In this episode, Kåre talks us […]
Why the CRO market is expected to reach over $110 Billion by 2028
What is a CRO? A Contract Research Organization (CRO) offers a range of outsourcing services to Biotechnology, Pharmaceutical and Medical Device companies with their main purpose being the planning, execution, coordination and development of a clinical trial. The CRO market can be broken down into different segments from early phase services, clinical research services, laboratory […]
The Importance of Mergers & Acquisitions in Pharma
Mergers and Acquisitions play an instrumental role in growth strategies & development for almost every pharmaceutical organisation. Over the last 30 years, M&A’s have led to considerable strengthening across pharmaceutical companies, Biotech’s, CRO’s, CDMO’s, and many more. Especially over the last two years, big pharma companies have orchestrated megadeals, to deliver across the board, […]
Mantell Associates Network: Q&A with Peter Worsöe
As part of the Mantell Associates Network podcast earlier last year, CEO Alessandro Mantell welcomed Peter Worsöe. On Episode 16 of the Mantell Associates Network Podcast we welcomed Peter Worsöe, CEO at AstaReal. In this episode Alessandro Mantell speaks with Peter Worsöe, covering everything from leadership during COVID-19, the best ways to motivate a team, […]
How Elon Musk’s Neuralink is Shaping the Medical Device Industry in 2022
In 2021, I covered a lot of areas within the Medical Device market from Surgical, Diagnostics, Liquid Handling to Biosciences and more. I took a strong interest in different companies’ technology, mission, and success. At the beginning of 2022 a new cutting-edge technology was seen on the horizon produced by Elon Musk. The Tesla kingpin […]
A Candidate Short Market
The term “candidate short” market means that there are more available positions than potential candidates. This may be seen as a negative thing however it can be used to your advantage. You will still have to impress your potential new employer in the interviews but you will most likely be competing against few applicants […]
Five key market observations from 2021…
In 2021, I covered Large Molecule CDMO, making appointments from mid to senior level across almost every business department. I spoke with thousands of people over the telephone, met many more in the flesh and built a network of key contacts. From these countless conversations, I was able to gain a real insight into the […]